6 Committee comments
6.1 The committee noted that there are several ongoing studies using extracorporeal carbon dioxide removal (ECCO2R) in patients with acute exacerbation of chronic obstructive pulmonary disease. It may also be used to support weaning from ventilation and as a bridge to lung transplantation.
6.2 The committee noted that the technology for this procedure is evolving.
6.3 The committee noted that, although complications reported in the studies were common, patients selected for treatment by ECCO2R had severe and life‑threatening disease.